Loading clinical trials...

Theophylline for Treatment of Pseudohypoparathyroidism | Clinical Trials | Clareo Health

Enrolling By InvitationPhase 2NCT04240821

Theophylline for Treatment of Pseudohypoparathyroidism

Pseudohypoparathyroidism is a genetic disorder with limited treatment options, characterized by early-onset obesity, short stature, hormone resistance and cognitive impairment. This phase 2 clinical t...

Lead sponsor: Ashley Shoemaker•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Active Not RecruitingPhase 2

Theophylline Treatment for Pseudohypoparathyroidism

NCT03029429 · Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy

COMPLETEDPhase 2

Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy)

NCT02463409 · Pseudohypoparathyroidism Type 1a, Albright Hereditary Osteodystrophy

COMPLETED

Study of the Regulation of Parathyroid Hormone Secretion in Pseudohypoparathyroidism

NCT00004661 · Pseudohypoparathyroidism

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 23, 2026Terms

Trial snapshot

StatusENROLLING_BY_INVITATION

PhasePHASE2

Enrollment34

Start dateMay 2020

Last updatedFeb 23, 2026

Condition

Pseudohypoparathyroidism Pseudohypoparathyroidism Type 1a Albright Hereditary Osteodystrophy

Locations shown

Vanderbilt University Medical Center

Nashville, Tennessee

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 23, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions